Deerfield Management Co., 10% Owner at ANTARES PHARMA, INC. (ATRS), sold 698,030 shares at $2.43 ($1.7M) on 2015-06-12, disclosed to the SEC on 2015-06-15.
Open-market sale of $1.7M ATRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 28,574 | $71K | 4.1% |
| 2 | $2.47 | 67,627 | $167K | 9.8% |
| 3 | $2.47 | 86,071 | $213K | 12.5% |
| 4 | $2.48 | 58,251 | $144K | 8.5% |
| 5 | $2.48 | 74,137 | $184K | 10.8% |
| 6 | $2.48 | 24,612 |
| $61K |
| 3.6% |
| 7 | $2.43 | 44,010 | $107K | 6.3% |
| 8 | $2.43 | 7,838 | $19K | 1.1% |
| 9 | $2.43 | 18,551 | $45K | 2.6% |
| 10 | $2.43 | 18,595 | $45K | 2.6% |
| 11 | $2.43 | 23,611 | $57K | 3.4% |
| 12 | $2.43 | 56,012 | $136K | 8.0% |
| 13 | $2.40 | 69,198 | $166K | 9.7% |
| 14 | $2.40 | 15,866 | $38K | 2.2% |
| 15 | $2.40 | 22,973 | $55K | 3.2% |
| 16 | $2.40 | 54,370 | $130K | 7.6% |
| 17 | $2.40 | 5,267 | $13K | 0.7% |
| 18 | $2.40 | 12,467 | $30K | 1.8% |
| 19 | $2.41 | 3,710 | $9K | 0.5% |
| 20 | $2.41 | 4,722 | $11K | 0.7% |
| 21 | $2.41 | 1,568 | $4K | 0.2% |
| Total | $2.44 avg | 698,030 | $1.7M | 100% |
| Filing → |
| CASM | SELL | 2017-01-23 | $314K | — | Filing → |
| ZFGN | SELL | 2016-08-01 | $4.4M | — | Filing → |
| EHTH | SELL | 2016-06-02 | $1.4M | — | Filing → |